nr_EUA 27205.275_281_284_Janssen COVID-19 Vaccine_Concurrence Letter_Expriy Extension_9 months to 11 Months

nr_EUA 27205.275_281_284_Janssen COVID-19 Vaccine_Concurrence Letter_Expriy Extension_9 months to 11 Months

April 18th, 2022 | nr_EUA-27205.275_281_284_Janssen-COVID-19-Vaccine_Concurrence-Letter_Expriy-Extension_9-months-to-11-Months